When Nader AlSalim and his wife were navigating the complex world of fertility treatment, the process was marked by stress and financial strain. But after finally achieving a successful outcome, AlSalim recognized how different his experience was from many others in his position. Gaia is working on building what AlSalim believes is a fundamentally new category in the $39 billion fertility market. The company uses artificial intelligence and machine learning ' trained on millions of anonymized historical data points and fertility outcomes ' to better understand risk and probability for fertility treatment. The platform analyzes variables such as age, hormone levels, ovarian response, treatment protocols, embryo development and clinical outcomes to direct patients to 'optimal' clinics based on their data profiles, and to generate personalized forecasts around fertility success. It also uses AI and machine learning to underwrite personalized outcome-based 'flexible' financing plans for...
learn more
